Impact of Pharmacist Led Intervention Study (PLIS)-Trial on Improving Bone Health of Epileptic Women

KG Hospital and Postgraduate Research Institute0 个研究点目标入组 100 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Female patients diagnosed with epilepsy and under anti-epileptic drug therapy for at least a period of two years
•The patient aged 15 to 45
•Patients with same characteristics both physically as well as clinically
•Both in-patients and out-patients of department of Neurology.
•The patients who are keeping up their regular follow-up appointments.
•The patient who are willing to give informed content.

•Pre-pubertic girls and postmenopausal women.
•Patients with conditions known to affect bone metabolism such as hepatic or renal disorders, hypothyroidism, or malabsorption.
•Patients with a history of intake of pharmacologic amounts of medications that can affect bone turn over (e.g., Vitamin A, anabolic steroids, bisphosphonates, glucocorticoids, thiazides, calcitonin)
•Patients from pediatrics, pregnant women, gynecological patients with hormone imbalance and emergency
•Psychiatric patients
•Patients not coming for regular follow up
•Patients who are not willing to participate in the study

发起方

KG Hospital and Postgraduate Research Institute